Plain-English translation of NCT05643144 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to present continuous glucose monitoring data—the information from a small sensor that tracks blood sugar throughout the day. The study is designed specifically for people living with both memory loss (like Alzheimer's disease) and diabetes, along with their caregivers. Researchers are creating easier-to-understand reports and interactive guides to help patients and caregivers work together with their doctors to make safer decisions about diabetes treatment.
People with both memory loss and diabetes face a dangerous problem: low blood sugar can happen without warning, and it can make memory problems worse. At the same time, memory loss makes it harder to notice and manage blood sugar safely. Standard glucose monitors exist, but the data they show is confusing and hard for patients and caregivers to understand—which stops them from working together with doctors to make important treatment changes.
You likely qualify if…
You likely don't qualify if…
You and your caregiver would wear a small continuous glucose monitor (a sticky sensor on your arm that checks blood sugar every 5 to 15 minutes) and meet with the research team to share your feedback on how easy the new reports are to understand. Depending on which part of the study you join, you may also participate in design sessions with doctors, nurses, and other care team members to help create the final version of the glucose monitoring reports. The research team will work with you over several months to test and refine these tools.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
United States